• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于区分阿尔茨海默病性痴呆与正常对照的[F]Florapronol正电子发射断层显像的SUVR截断值:来自ROC分析和部分容积校正的见解

Cutoff SUVR of [F]Florapronol PET for Differentiating Alzheimer's Dementia from Normal Controls: Insights from ROC Analysis and Partial Volume Correction.

作者信息

Park Su Yeon, Lee Inki, Lim Ilhan, Kim Byung Il, Choi Chang Woon, Ko In Ok, Byun Byung Hyun, Ha Jeong Ho

机构信息

Departments of Neurology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences (KIRAMS), 75 Nowongil, Nowon Gu, Seoul, 139-706 Republic of Korea.

Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences (KIRAMS), 75 Nowongil, Nowon Gu, Seoul, 139-706 Republic of Korea.

出版信息

Nucl Med Mol Imaging. 2025 Aug;59(4):229-238. doi: 10.1007/s13139-025-00911-7. Epub 2025 Feb 20.

DOI:10.1007/s13139-025-00911-7
PMID:40686829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12267780/
Abstract

OBJECTIVES

The primary endpoint of this study is to establish a reliable SUVR cutoff threshold to distinguish patients with Alzheimer's disease (AD), excluding those with mild cognitive impairment (MCI), from normal control (NC) individuals using [F]florapronol PET imaging and deep learning-based automated quantification software. The secondary endpoint is to evaluate whether combining partial volume correction (PVC) with SUVR analysis improves diagnostic accuracy in detecting AD.

METHODS

A total of 141 participants, including 55 AD patients (excluding MCI) and 86 NC controls, were enrolled. Each participant underwent [F]florapronol PET imaging, and SUVR values were calculated for six amyloid-prone brain regions using deep learning-based software. SUVRs were computed with and without PVC, using the cerebellar cortex as the reference region. Receiver operating characteristic (ROC) analysis identified optimal SUVR thresholds for distinguishing AD (excluding MCI) from NC and for determining visual positivity. Age-matched subgroup analyses ensured consistent diagnostic performance across different age groups.

RESULTS

In the full cohort ( = 141), visual analysis achieved a sensitivity of 90.9% and specificity of 94.1% for distinguishing AD from NC. SUVR without PVC reached a similar sensitivity of 90.9% and specificity of 86.0% (optimal threshold > 1.26), while PVC-adjusted SUVR further improved accuracy with a sensitivity of 90.9% and specificity of 94.2% at a threshold of > 1.31. For visual positivity, SUVR without PVC achieved 92.7% sensitivity and 89.5% specificity, while PVC-adjusted SUVR improved these metrics to 96.4% sensitivity and 94.2% specificity. Age-matched analyses confirmed diagnostic consistency across different age groups. The visual analysis and the quantitative analysis using SUVR with PVC as the threshold were consistent in 134 out of 141 subjects (95.0%).

CONCLUSIONS

Automated SUVR quantification with PVC adjustment provides a reliable and objective method for distinguishing AD from NC, aligning closely with visual assessment accuracy and supporting clinical use of [F]florapronol PET imaging for AD diagnosis. This standardized approach enhances diagnostic consistency, particularly in settings with limited access to PET specialists, and establishes robust SUVR thresholds for broader clinical application in amyloid PET imaging.

摘要

目的

本研究的主要终点是使用[F]氟罗普诺正电子发射断层扫描(PET)成像和基于深度学习的自动定量软件,建立一个可靠的标准化摄取值比率(SUVR)截止阈值,以区分阿尔茨海默病(AD)患者(不包括轻度认知障碍(MCI)患者)与正常对照(NC)个体。次要终点是评估将部分容积校正(PVC)与SUVR分析相结合是否能提高检测AD的诊断准确性。

方法

共招募了141名参与者,包括55名AD患者(不包括MCI)和86名NC对照。每位参与者均接受了[F]氟罗普诺PET成像,并使用基于深度学习的软件计算了六个易发生淀粉样蛋白沉积的脑区的SUVR值。使用小脑皮质作为参考区域,分别计算有和没有PVC时的SUVR。通过受试者操作特征(ROC)分析确定区分AD(不包括MCI)与NC以及确定视觉阳性的最佳SUVR阈值。年龄匹配的亚组分析确保了不同年龄组的诊断性能一致。

结果

在整个队列(n = 141)中,视觉分析区分AD与NC的灵敏度为90.9%,特异性为94.1%。未进行PVC校正的SUVR达到了相似的灵敏度90.9%和特异性86.0%(最佳阈值>1.26),而经PVC校正的SUVR进一步提高了准确性,在阈值>1.31时,灵敏度为90.9%,特异性为94.2%。对于视觉阳性,未进行PVC校正的SUVR灵敏度为92.7%,特异性为89.5%,而经PVC校正的SUVR将这些指标提高到了灵敏度96.4%,特异性94.2%。年龄匹配分析证实了不同年龄组的诊断一致性。在141名受试者中有134名(95.0%)的视觉分析和以经PVC校正的SUVR为阈值的定量分析结果一致。

结论

经PVC校正的自动SUVR定量为区分AD与NC提供了一种可靠且客观的方法,与视觉评估准确性密切相关,并支持[F]氟罗普诺PET成像在AD诊断中的临床应用。这种标准化方法提高了诊断一致性,特别是在PET专家资源有限的情况下,并为淀粉样蛋白PET成像在更广泛的临床应用中建立了可靠的SUVR阈值。

相似文献

1
Cutoff SUVR of [F]Florapronol PET for Differentiating Alzheimer's Dementia from Normal Controls: Insights from ROC Analysis and Partial Volume Correction.用于区分阿尔茨海默病性痴呆与正常对照的[F]Florapronol正电子发射断层显像的SUVR截断值:来自ROC分析和部分容积校正的见解
Nucl Med Mol Imaging. 2025 Aug;59(4):229-238. doi: 10.1007/s13139-025-00911-7. Epub 2025 Feb 20.
2
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
3
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
4
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
5
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
6
Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.预测认知衰退:深度学习揭示轻度认知障碍前阶段大脑的细微变化。
J Prev Alzheimers Dis. 2025 May;12(5):100079. doi: 10.1016/j.tjpad.2025.100079. Epub 2025 Feb 6.
7
Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.用于检测疑似痴呆患者额颞叶痴呆的局部脑血流单光子发射计算机断层扫描
Cochrane Database Syst Rev. 2015 Jun 23;2015(6):CD010896. doi: 10.1002/14651858.CD010896.pub2.
8
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.用于诊断神经母细胞瘤的123I-间碘苄胍闪烁扫描术和18F-氟代脱氧葡萄糖正电子发射断层显像
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.
9
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
10
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).用于检测轻度认知障碍(MCI)患者中阿尔茨海默病及其他痴呆症的简易精神状态检查表(MMSE)。
Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2.